并购市场热度飙升！嘉能可成2026年欧洲“头号猎物” 买家“广撒网”寻潜在标的

Group 1 - Glencore is identified as the most likely European company to be acquired by 2026, with ongoing merger talks with Rio Tinto to create the world's largest mining company [1] - The global M&A environment is becoming increasingly active, with announced M&A deal value exceeding $63 billion as of January 23, 2023, which is more than three times the amount recorded in the same period in 2025 [2] - The merger discussions between Rio Tinto and Glencore are at their closest point in decades, with Glencore's CEO describing it as the most obvious merger in the mining sector [6] Group 2 - Abivax SA, a French biotech company, has been mentioned multiple times as a potential acquisition target, with its stock price surging over 1600% in 2025 due to acquisition prospects and positive drug trial results [1] - BP, Delivery Hero, EasyJet, and Great Portland Estates are also highlighted as attractive acquisition targets, each mentioned four times in the survey [1] - The FTSE 100 index is trading at a discount of approximately 15% compared to the Euro Stoxx 50 index and 40% compared to the S&P 500 index, making UK-listed companies appealing to acquirers [8] Group 3 - BP's cash reserves account for about 40% of its market value, indicating potential interest from buyers [12] - Great Portland Estates is seen as a potential "flagship acquisition target" for sovereign wealth funds due to its real estate investment trust structure limiting its reinvestment capabilities [12] - EasyJet's trading price is significantly discounted compared to competitors, making it attractive for acquirers seeking substantial synergies [12] Group 4 - Abivax's appeal stems from its candidate drug obefazimod, which is being studied for treating inflammatory bowel disease, attracting interest from major companies like AstraZeneca and Eli Lilly [13]